2-((4-(2,4-Dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide

Catalog No. :
ACTECB655
CAS No. :
835891-94-6
Molecular Formula :
C26H22N6O2S2
Molecular Weight :
514.64

IUPAC Name:2-((4-(2,4-dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide

2-((4-(2,4-Dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-(2,4-Dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide
IUPAC Name2-((4-(2,4-dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide
Molecular FormulaC26H22N6O2S2
Molecular Weight514.64
SMILESO=C(NC1=NN=C(C2=CC=CC=C2)S1)CSC3=NN=C(C4=CC=CC=C4O)N3C5=CC=C(C)C=C5C
InChI KeyYMTQXAQHXBAUQU-UHFFFAOYSA-N
Synonym2-{[4-(2,4-dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(5-phenyl-1,3,4-thiadiazol-2-yl)acetamide;Acetamide, 2-[[4-(2,4-dimethylphenyl)-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]thio]-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-
CAS No.835891-94-6

Synthetic Route by SureRoute

1. ACTECB655 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQYUO692 route compound structure diagram
    ACQYUO6922002-03-1 In Stock
  4. Then
  5. ACTECB655 route product structure diagram
    ACTECB655835891-94-6
Inquiry

2. ACTECB655 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTECB655 route product structure diagram
    ACTECB655835891-94-6
Inquiry

Comments (0)